Skip to main content
SpringerLink
Log in

Selected Disorders of the Female Reproductive System

  • Chapter
Family Medicine

  • 24 Accesses

Abstract

Pelvic inflammatory disease (PID) is a clinical syndrome comprising infection and inflammation of the upper genital tract; it encompasses endometritis, salpingitis, tuboovarian abscess, and pelvic peritonitis.1 One million women a year are treated for acute PID at an annual cost of more than $4 billion.2 At least one-fourth of women with PID suffer serious sequelae (infertility, ectopic pregnancy, chronic pelvic pain) and are at risk for major abdominal or pelvic surgery (tuboovarian abscess, pelvic adhesive disease). Teenagers comprise one-fifth of the total cases, and the rate for adolescent girls has continued to rise, especially for white girls.3,4

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Antimicrobial therapy for gynecologic infections. Technical Bulletin No. 153. Washington, DC: American College of Obstetricians and Gynecologists, 1991.

    Google Scholar 

  2. Washington AE, Katz P. Cost of and payment source for pelvic inflammatory disease: trends and projections, 1983 through 2000. JAMA 1991;266:2565–9.

    Article  PubMed  CAS  Google Scholar 

  3. Washington AE, Sweet RL, Shafer MA. Pelvic inflammatory disease in the adolescent female and its sequelae. J Adolesc Health Care 1985;6:298–310.

    Article  PubMed  CAS  Google Scholar 

  4. Shafer MA, Sweet RL. Pelvic inflammatory disease in adolescent females: epidemiology, pathogenesis, diagnosis, treatment, and sequelae. Pediatr Clin North Am 1989;36:513–31.

    PubMed  CAS  Google Scholar 

  5. Westrom L. Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol 1975;121:707–13.

    PubMed  CAS  Google Scholar 

  6. Holmes KK, Eschenbach DA, Knapp JS: Salpingitis: overview of etiology and epidemiology. Am J Obstet Gynecol 1980;138:893–900.

    PubMed  CAS  Google Scholar 

  7. Eschenback DA. Acute pelvic inflammatory disease. Urol Clin North Am 1984;11:65–81.

    Google Scholar 

  8. Wolner-Hanssen P, Eschenback DA, Paavonen J, et al. Association between vaginal douching and acute pelvic inflammatory disease. JAMA 1990;263:1936–41.

    Article  PubMed  CAS  Google Scholar 

  9. Vermesh M, Confino E, Boler LR, Freiberg J, Gleicher N. Acute salpingitis in sterilized women. Obstet Gynecol 1987;69:265–7.

    PubMed  CAS  Google Scholar 

  10. Wolner-Hanssen P, Kiviat NB, Holmes KK. Atypical pelvic inflammatory disease: subacute, chronic, or subclinical upper genital tract infection in women. In: Holmes KK, Mardh P-A, Sparling PF, et al, editors. Sexually Transmitted Diseases. 2nd ed. New York: McGraw-Hill, 1989:615–20.

    Google Scholar 

  11. Shepard MK, Jones RB. Recovery of Chlamydia trachomatis from endometrial and fallopian tube biopsies in women with infertility of tubal origin. Fertil Steril 1989;52:232–8.

    PubMed  CAS  Google Scholar 

  12. Jacobson L, Westrom L. Objectivized diagnosis of acute pelvic inflammatory disease: diagnostic and prognostic value of routine laparoscopy Am J Obstet Gynecol 1969;105:1088–98.

    PubMed  CAS  Google Scholar 

  13. Hager WD, Eschenback DA, Spence MR, Sweet RL. Criteria for diagnosis and grading of salpingitis. Obstet Gynecol 1983;61:113–4.

    PubMed  CAS  Google Scholar 

  14. Hinman AR, Cates W Jr. Pelvic inflammatory disease: guidelines for prevention and management; and Hinman AR, Snider DE, O’Brien RJ, purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR 1991;40:1–25.

    Google Scholar 

  15. Burnakis TG, Hildebrandt NB. Pelvic inflammatory disease: a review with emphasis on antimicrobial therapy. Rev Infect Dis 1986;8:86–116.

    Article  PubMed  CAS  Google Scholar 

  16. Crombleholme WR, Schacter J, Ohm-Smith M, Luft J, Whhidden R, Sweet RL. Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin. Am J Med 1989;87:142s-7s.

    Article  Google Scholar 

  17. Washington AE, Cates W Jr, Wasserheit JN. Preventing pelvic inflammatory disease. JAMA 1991;266:2574–80.

    Article  PubMed  CAS  Google Scholar 

  18. Berg AO. The primary care physician and sexually transmitted disease control. In: Holmes KK, Mardh P-A, Sparling PF, Wiesner PJ, editors. Sexually transmitted disease. 2nd ed. New York: McGraw-Hill, 1990:1095–8.

    Google Scholar 

  19. Sampson, JA. Perforating hemorrhagic (chocolate) cysts of the ovary, their importance and especially their relation to pelvic adenomas of the endometrial type. Arch Surg 1921;3:254–323.

    Article  Google Scholar 

  20. Saltiel E, Garabedian-Ruffalo SM. Pharmacologic management of endometriosis. Clin Pharm 1991;10:518–30.

    PubMed  CAS  Google Scholar 

  21. Dawood MY. Endometriosis. In: Gold JJ, Josimovich JB, editors. Gynecologic endocrinology. New York: Plenum, 1987:387–404.

    Chapter  Google Scholar 

  22. Moghissi KS. Office management of endometriosis. In: Sten-chever MA, editor. Office gynecology. St. Louis: Mosby Year Book, 1992:413–29.

    Google Scholar 

  23. National Center for Health Statistics, McCarthey E. Inpatient utilization of short-stay hospitals by diagnosis: United States, 1980. Hyattsville, MD: National Center for Health Statistics, 1982; DHSS Publ. No. (PHS) 83–1735. (Vital and health statistics; series 13: Data from the National Health Survey, no. 74.)

    Google Scholar 

  24. Hurst BS, Rock JA. Endometriosis: pathophysiology, diagnosis, and treatment. Obstet Gynecol Surv 1989:44:297–304.

    Article  PubMed  CAS  Google Scholar 

  25. Speroff L, Glass RH, Kase NG, editors. Clinical gynecology, endocrinology, and infertility. 4th ed. Baltimore: Williams & Wilkins, 1989:547–63.

    Google Scholar 

  26. Dmowski WP. Endometriosis. In: Glass RH, editor. Office gynecology. Baltimore: Williams & Wilkins; 1987:317–36.

    Google Scholar 

  27. Management of endometriosis. Technical Bulletin No. 85. Washington, DC: American College of Obstetricians and Gynecologists, 1985.

    Google Scholar 

  28. Pittaway DE. CA-125 in women with endometriosis. Obstet Gynecol Clin North Am 1989;16:237–52.

    PubMed  CAS  Google Scholar 

  29. Seibel MM. Does minimal endometriosis always require treatment? Contemp Obstet Gynecol 1989;34(l):27–39.

    Google Scholar 

  30. DiZerega GS, Barber DL, Hodgen GD. Endometriosis: role of ovarian steroids in initiation, maintenance, and suppression. Fertil Steril 1980;33:649–53.

    PubMed  CAS  Google Scholar 

  31. Barbieri RL. Endometriosis 1990: current treatment approaches. Drugs 1990;39:502–10.

    Article  PubMed  CAS  Google Scholar 

  32. Overcoming endometriosis: new help from the Endometriosis Association. Milwaukee: Endometriosis Association, 1992.

    Google Scholar 

  33. Important facts about endometriosis. Washington, DC: American College of Obstetrics and Gynecologists, 1992.

    Google Scholar 

  34. Horn MC, Mosher WD. Use of services for family planning and infertility. United States, 1982, advance data from vital and health statistics, 1984; No. 103. Hyattsville, MD: US Public Health Service, Department of Health and Human Services.

    Google Scholar 

  35. Mosher WD. Infertility trends among U.S. couples: 1965–1976. Fam Plann Perspect 1982;14:22–7.

    Article  PubMed  CAS  Google Scholar 

  36. Speroff L, Glass RH, Kase NG, editors. Investigation of the infertile couple. 4th ed. Baltimore: Williams & Wilkins, 1989:513–46.

    Google Scholar 

  37. Zarutskie PW. Evaluation of the infertile couple. In: Stenchever MA, editor. Office gynecology. St. Louis: Mosby Year Book, 1992:441–70.

    Google Scholar 

  38. Infertility. Technical Bulletin No. 125. Washington, DC: American College of Obstetricians and Gynecologists; 1989.

    Google Scholar 

  39. Davajan V. Workup of the infertile couple. In: Mishell DR, Brenner PF, editors. Management of common problems in obstetrics and gynecology. Oradell, NJ: Medical Economics Books, 1984: 387–93.

    Google Scholar 

  40. RESOLVE National Headquarters, 5 Water Street, Arlington, MA 02174.

    Google Scholar 

  41. Todd J, Fishaut M. Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet 1978;2:1116–8.

    Article  PubMed  CAS  Google Scholar 

  42. Tofte RW, Williams DN. Toxic shock syndrome: evidence of a broad clinical spectrum. JAMA 1981;246:2163–7.

    Article  PubMed  CAS  Google Scholar 

  43. Bryner CL Jr. Recurrent toxic shock syndrome. Am Fam Physician 1989;39:157–64.

    PubMed  Google Scholar 

  44. Davis JP, Chesney PJ, Wand PJ, LaVenture M. Toxic shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 1980;303:1429–35.

    Article  PubMed  CAS  Google Scholar 

  45. Centers for Disease Control. Summary of notifiable disease, United States. MMWR 1988;37:40.

    Google Scholar 

  46. Litt IF. Toxic shock syndrome—an adolescent disease. J Adolesc Health Care 1983;4:270–4.

    Article  PubMed  CAS  Google Scholar 

  47. Reingold AL, Hargrett NT, Dan BB, Shands KN, Strickland BY, Broome CV Nonmenstrual toxic shock syndrome: a review of 130 cases. Ann Intern Med 1982;96:871–4.

    Article  PubMed  CAS  Google Scholar 

  48. Gallo UE, Fontanarosa PB. Toxic streptococcal syndrome. Ann Intern Med 1990;19:1332–4.

    CAS  Google Scholar 

  49. Resnick SD. Toxic shock syndrome: recent developments in pathogenesis. J Pediatr 1990;116:321–8.

    Article  PubMed  CAS  Google Scholar 

  50. Parsonnet J. Mediators in the pathogenesis of toxic shock syndrome: overview. Rev Infect Dis 1989;2 Suppl l:s263–9.

    Google Scholar 

  51. Tofte R, Williams DN. Toxic shock syndrome: clinical and laboratory features in 15 patients. Ann Intern Med 1981;94:149–56.

    Article  PubMed  CAS  Google Scholar 

  52. Davis JP, Osterholm MT, Helms CM, et al. Tri-state toxic-shock syndrome study: clinical and laboratory findings. J Infect Dis 1982;145:441–8.

    Article  PubMed  CAS  Google Scholar 

  53. Todd JK. Therapy of toxic shock syndrome. Drugs 1990;39:856–61.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Gary R. Newkirk
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Family Medicine, Oregon Health Sciences University, School of Medicine, Portland, 97201, OR, USA

    Robert B. Taylor M.D. (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Newkirk, G.R. (1994). Selected Disorders of the Female Reproductive System. In: Taylor, R.B. (eds) Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-4005-9_109

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-4005-9_109

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4757-4007-3

  • Online ISBN: 978-1-4757-4005-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation